{{Rsnum
|rsid=5574
|Gene=NPY
|Chromosome=7
|position=24289514
|Orientation=plus
|GMAF=0.4151
|Gene_s=NPY
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 29.2 | 45.1 | 25.7
| HCB | 41.5 | 50.4 | 8.1
| JPT | 47.8 | 39.8 | 12.4
| YRI | 40.8 | 44.9 | 14.3
| ASW | 42.1 | 49.1 | 8.8
| CHB | 41.5 | 50.4 | 8.1
| CHD | 36.7 | 55.0 | 8.3
| GIH | 45.0 | 47.0 | 8.0
| LWK | 40.9 | 47.3 | 11.8
| MEX | 31.0 | 46.6 | 22.4
| MKK | 31.0 | 61.9 | 7.1
| TSI | 25.5 | 51.0 | 23.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23277265
|Title=Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients
}}

{{PMID Auto
|PMID=17357083
|Title=Medical sequencing at the extremes of human body mass.
|OA=1
}}

{{PMID Auto
|PMID=18385673
|Title=Genetic variation in human NPY expression affects stress response and emotion.
|OA=1
}}

{{PMID Auto
|PMID=18828811
|Title=Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence.
|OA=1
}}

{{PMID Auto
|PMID=19119412
|Title=Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=21390334
|Title=Genetic polymorphisms in the hypothalamic pathway in relation to subsequent weight change--the DiOGenes study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}